Tomas

[Tomas @TomasBaltrunas]

@SamoskaPaulius @Sentante_robot @ung_investor This was huge, but even more is coming this month together with:
@drricardohanel
@vitorpereiracan
@CostalatV
and many others

[Paulius Samoska @SamoskaPaulius]

Historisk milepæl innen medisin robotics!

@Sentante_robot - a Lithuanian medtech startup - has achieved the world’s first transatlantic remote stroke surgery, connecting University of Dundee 🇬🇧 and Baptist Health 🇺🇸.
Great achievement @TomasBaltrunas

@ung_investor noe for deg å sjekke ;)

Article from BBC below 👇
https://t.co/zs1HwdJjjz

[Endovascular Today @EVToday]

Sentante Stroke System Receives FDA Breakthrough Device Designation | @Sentante_robot https://t.co/XhFE22u6VU

[Tech.eu @tech_eu]

Lithuania’s Sentante achieves transatlantic first in remote robotic stroke intervention https://t.co/ONhxL11qc5

[Tomas @TomasBaltrunas]

@jmills1955 @gloviczki @UPMC @CanadianSVS @VascularSVS @UPMC_Vascular @BCM_Surgery @GustavoOderich @VASCevidence @VenerMa @mabjo425 @AlanLumsdenMD One of the best talks touching the topic we are skipping so often

[Tomas @TomasBaltrunas]

@AlanLumsdenMD One of possible solutions @Sentante_robot is just next to registration desks at @VEITHsymposium

[Tomas @TomasBaltrunas]

@Sentante_robot was presented in this nice event. Thanks @AlanLumsdenMD for coming and hands on testing the system

[Alan Lumsden, MD, CV Chairman/Director @AlanLumsdenMD]

https://t.co/uExCN9srrY

[Athanasios Saratzis @a_saratzis]

I urge every vascular surgeon & healthcare professional to look at the rate at which our cardiology friends are recruiting people with ⬆️ high-risk pathologies to RCTs answering difficult research questions, such as the @easyas_trial. We have NO excuse! @VSGBI @VascResearchUK

[Tomas @TomasBaltrunas]

Join Us at the Vilnius Vascular Symposium!
The biggest vascular conference in the Baltic region will be held 3rd-4th October, 2024 in Vilnius old town.
More information https://t.co/VpcuUtH4RX

Thanks to the sponsors:
@inspiremd, @Medtronic , @terumoisuk and many others

[Tomas @TomasBaltrunas]

Zero X-Ray exposure to all medical personnel with @Sentante_robot
Thanks Max Amor, Konstantinos Stavroulakis, @vascularIR, Giovanni F. Torsello for your kind support

[Sentante @Sentante_robot]

Our GLP animal study exceeded expectations and showcased extraordinary results. This milestone marks an important step forward in our journey! @VeranexSolution

[Vascupedia @Vascupedia_com]

How much does a TLR cost? | The findings of the COSTLY TLR Study

🎙 Prof. Dr. Giovanni Torsello 🇩🇪
🗣 @a_saratzis 🇬🇧
🗣 @K_Stavroulakis 🇩🇪 
🗓 16/04/24 | 🕔 5pm CET
🖥 https://t.co/p4dQmhtdhB

Login
Name: [email protected] Password: webinar

[Tomas @TomasBaltrunas]

@AlanLumsdenMD Maybe you are comming to #linc in Leipzig this year? Would be happy to demonstrate (with hands on testing) a next generation endovascular robot @Sentante_robot

[Tomas @TomasBaltrunas]

@KiprasJauniskis?

[David G. Armstrong follow @dgarmstrong.bsky.social @DGArmstrong]

Fellows wanted. Mentors available. The Lawrence B. Harkless Fellowship in Limb Preservation @USC is open for applicants https://t.co/T6OOIAkVbt

[BalticVC @BalticVC]

#Kaunas-based startup @Sentante_robot, which manufactures a fully robotic teleoperated system for endovascular interventions, raised €6M from lead #investor Lithuanian @PracticaCapital with the participation of @EUeic (the investment arm of the European Innovation Council).

Founded in 2020 by @TomasBaltrunas, Edvardas Satkauskas, Vilius Dambrauskas, Evaldas Kalvaitis, and Vaidas Labunskas, Sentante developed a sensory, teleoperated robot system, that allows the endovascular intervention of cardiovascular diseases, such as stroke, #heartattacks, and peripheral artery disease. As a result, physicians and medical teams can work without being exposed to harmful X-ray radiation. Currently, this procedure is performed manually, and apart from prolonged X-ray exposure on surgeons and nurses, it has a high risk of medical errors and complications due to the non-ergonomic workspace.

Sentante's robot system is controlled intuitively with the help of endovascular devices such as guidewires and catheters. The device senses the surgeon's movements, providing a near-natural haptic force feedback experience. At the same time, the physicians can feel the catheter and guidewire resistance as if they were standing near the patient. In the future, Sentante expects to perform endovascular treatment from a remote #hospital or another town.

The startup will use the investment for the planned clinical trial of the Sentante robotic system and preparation for commercial launch in international markets. The company plans to start its first-in-human clinical study in 2024.

In 2021, Sentante was accepted into the EIC Accelerator and received blended financial support from it. Back then, the accelerator provided the startup with €2,5M grant, and this year, it received equity investment. In 2023, Sentante also joined the non-equity acceleration program of #LosAngeles-based MedTech Innovator. The company was selected out of 1,1K companies.

Founded in 2012, Vilnius-based Practica Capital focuses on investments in the Baltic and Baltic-origin ventures in Europe. It has made over 60 investments and has supported Lithuanian startups PVcase, Interactio, Oxipit, Atrandi, Biomatter Designs, Montonio, Ovoko, London-based TransferGo, and others. Practica Capital manages four funds with a total market value of the investments (AUM) of €130M. Practica's partners are Tomas Andriuškevičius, Gintas Daniusevičius, Anatolijus Faktorovicius, and @ArvydasBloze. The founding partner is @DonatasKeras.

EIC Accelerator offers startups grants of up to €2,5M, which can be combined with equity investments from €0,5M to €15M. The equity investments are provided by the EIC Fund. In addition to financial support, all projects benefit from a range of Business Acceleration Services that provide access to expertise, corporates, investors, and ecosystem actors. The application and evaluation process in the accelerator program is managed by the EIC and SMEs Executive Agency (EISMEA).

#MedTech #Lithuania #startup #startups #tech #technology #technologies #TechnologyNews #TechNews #Deal #Deals #VentureCapital #VC

[Tomas @TomasBaltrunas]

@vascularIR @UkVenous @YsaAugust @ADiamantop @a_saratzis @EndovascularU @HadyLichaaMD @monteromiguel @MakisAvgerinos @CoPhlebology @DrSteveElias @marlobat @paulmoxey @lahinchman @vonstampy @PEO_APP FYA festival will proove that not every festival starting FY is going to fail

[Lorenzo Patrone @vascularIR]

https://t.co/B91G8kd6QZ What a circus (no clowns allowed)! 26-28 January 24 London. @UkVenous, @YsaAugust, M Lichtenberg and I as the ringmasters of the most interactive meeting of the year! Peripheral and venous parallel rooms @ADiamantop @a_saratzis @EndovascularU @HadyLichaaMD

[August Ysa @YsaAugust]

Don't miss the style of case-based presentations the attendants will encounter in the FYA congress 2024. https://t.co/OJCNwol6lC
January 26th-28th. London (UK).
It's all about discussion!
https://t.co/y6ZW0bKUDP

[Tomas @TomasBaltrunas]

@AlanLumsdenMD @monteromiguel @Sentante_robot We are planning to have a first public demonstration in CX London, April 2024. If it happens @AlanLumsdenMD visiting Europe - you are welcome to have hands on test anytime in our facilities

[Tomas @TomasBaltrunas]

@monteromiguel @hendolat @Vascupedia_com 0.014’’ typically. If failed, 0.035’’ sometimes might be a good solution